933P Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study
- Resource Type
- Source
- Annals of Oncology. 32:S819
- Subject
Oncology medicine.medical_specialty First line therapy business.industry Internal medicine Hepatocellular carcinoma medicine Hematology Pembrolizumab medicine.disease business - Language
- ISSN
- 0923-7534